皮肤手术后发生同形反应性鳞状细胞癌患者外观正常皮肤的的表观遗传通路改变与细胞周期失调
研究两例多发性硬化患者在接受富马酸二甲酯(DMF)治疗(此前长期使用硫唑嘌呤)期间,于皮肤鳞状细胞癌完整切除后快速发生多个同形反应性鳞状细胞癌(K-SCC)。对外观正常皮肤行免疫组化显示Ki-67、p16、p53表达较高,与原发性SCC及K-SCC相当,而健康对照皮肤几乎不表达;所有肿瘤及外观正常皮肤TET-2表达均降低。HPV DNA及BRAF、K-RAS、EGFR突变均阴性。
要点
- 两例多发性硬化患者在接受DMF治疗(此前长期使用硫唑嘌呤)期间,于SCC完整切除后快速发生多个K-SCC。
- 患者外观正常皮肤的Ki-67、p16、p53表达较高,与原发性SCC及K-SCC相当,健康对照皮肤几乎不表达。
- 所有肿瘤及外观正常皮肤TET-2表达均降低;所有病变HPV DNA阴性,未检测到BRAF、K-RAS、EGFR突变。
核心结论
- 在K-SCC患者外观正常皮肤中,伤口愈合过程(包括诱导增殖和生长因子释放)可能在既有表观遗传通路改变和细胞周期失调的基础上促进癌前角质形成细胞生长和癌症形成。
- 尽管富马酸盐可降低TET-2表达,但DMF摄入在K-SCC发生中的作用仍不明确。
研究设计与样本
- 对两例多发性硬化患者(接受DMF治疗,此前长期使用硫唑嘌呤)在组织病理学证实皮肤SCC完整切除后快速发生多个K-SCC的病例进行研究。
- 采用免疫组化检测p53、p16、Ki-67、TET-2、IDH-2、5-hmc和5-mc;PCR检测人乳头瘤病毒;对BRAF、K-RAS和EGFR进行突变分析。
主要发现
- 所有研究病变HPV DNA均为阴性,未检测到突变。
- 两例患者外观正常皮肤的Ki-67、p16和p53表达相对较高,与原发性SCC及K-SCC中观察到的表达相当。
- 健康对照标本中几乎检测不到Ki-67、p16和突变型p53的蛋白表达。
- 与健康对照皮肤相比,所有肿瘤及外观正常皮肤中TET-2酶蛋白表达降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Koebnerized non-melanoma skin cancer following skin trauma represents a rare and obscure event. OBJECTIVES: To study molecular pathological parameters in koebnerized squamous cell carcinomas (K-SCCs) occurring after complete tumour removal. METHODS: We assessed two patients with multiple sclerosis who were on treatment with dimethylfumarate (DMF) preceded by long-term azathioprine therapy. Both patients rapidly developed several K-SCCs following histopathologically proven complete excision of cutaneous SCCs. We performed immunohistochemistry for p53, p16, Ki-67, TET-2, IDH-2, 5-hmc and 5-mc. PCR was carried out for the detection of human papilloma viruses. Mutation analysis was performed for BRAF, K-RAS and EGFR. RESULTS: All lesions investigated were negative for HPV DNA. Mutations were not detected. Healthy appearing skin of both patients showed relatively high Ki-67, p16 and p53 expression which was comparable to the expression observed in primary SCCs as well as K-SCCs. Protein expression of Ki-67, p16 and mutant p53 was barely detected in the specimens of the healthy controls. A decreased protein expression of TET-2 enzyme was seen in all tumours and healthy appearing skin when compared to the skin of healthy controls. CONCLUSIONS: We observed two patients with K-SCCs developing under DMF treatment. In healthy appearing skin of patients with K-SCCs, wound healing processes, including induction of proliferation and growth factor release, might promote the growth of preneoplastic keratinocytes and cancer formation on the basis of pre-existing altered epigenetic pathways and cell cycle dysregulation. Although fumarates can reduce TET-2 expression, the role of DMF intake in the development of K-SCCs remains unclear.
引用
- Gambichler T, Rüddel I, Hessam S, et al. Altered epigenetic pathways and cell cycle dysregulation in healthy appearing skin of patients with koebnerized squamous cell carcinomas following skin surgery. J Eur Acad Dermatol Venereol. 2018. PMID: 29478287. doi:10.1111/jdv.14887
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。